-
Title
-
Adsorption of Favipiravir as Drug of Coronavirus Disease on Cu-Si52, Cu-C52, Cu-Al26N26, Cu-SiNT (6, 0), Cu-CNT (6, 0) and Cu-AlNT (6, 0)
-
Abstract
-
This work wants to investigate the potential of Cu-Si52, Cu-C52, Cu-Al26N26, Cu-doped nanotubes (6, 0) to adsorb and deliver the Favipiravir as COVID-19 drug by DSD-PBEPBE-D3/aug-cc-pVDZ method. This work aims to propose the suitable materials for drug delivery of Favipiravir as COVID-19 drug. Results indicated that the Cu adoption can be increased the stability of Si52, C52, Al26N26, SiNT (6, 0), CNT (6, 0) and AlNNT (6, 0), significantly. The ΔGadsorption of complexes of Favipiravir with Cu-Si52, Cu-C52, Cu-Al26N26, Cu-doped nanotubes (6, 0) are -3.14, -3.25, -3.40, -3.89, -4.03 and -4.13 eV, respectively. The recovery time (τ) values of complexes of Favipiravir with Cu-Si52, Cu-C52, Cu-Al26N26, Cu-doped nanotubes (6, 0) in gas phase are 50.0, 51.8, 55.0, 56.3, 58.3 and 63.0 s. The Cu-AlNNT (6, 0) and Cu-Al26N26 have higher recovery time (τ) than Cu-Si52, Cu-C52, Cu-doped nanotubes (6, 0). Results shown that the Cu-Si52, Cu-C52, Cu-Al26N26, Cu-doped nanotubes (6, 0) have higher capacitates and abilities to deliver and transfer of the Favipiravir than other nanostructures in previous works. Finally, the Cu-AlNNT (6, 0) and Cu-CNT (6, 0) are proposed as acceptable structures to deliver and transfer of Favipiravir as drug of Coronavirus disease.
-
Scientific Type
-
غير معروف
-
Journal volume
-
Volume 16
-
Collaboration type
-
مشترك
-
Publish Date
-
July 19, 2024
-
Scopus status
-
In Scopus
-
Scopus index year
-
2 024
-
Scopus quarter
-
2
-
Scopus citation score
-
6.300000191
-
Clarivate status
-
In Clarivate
-
Clarivate index year
-
2 024
-
Clarivate impafact
-
2.900000095
-
Pub. Med. status
-
Not In PubMed
-
ISSN
-
1876-990X
-
Country type
-
عالمية
Alnoor University
Springer Nature
Netherlands
College of Health and Medical Technologies
Department of Medical laboratories techniques